Development of medical countermeasures for biodefense and emerging diseases

  • Description
  • Details
  • Subprojects
  • History
  • Relations
  • Publications
Project Title: Development of medical countermeasures for biodefense and emerging diseases
Project Number: 272201300017C-18-0-1
Project web address: Follow on NIH
Organization: Biocryst Pharmaceuticals, Inc., United States, Alabama, BIRMINGHAM
Principal Investigators (PI): Taylor Raymond, US
 
Project Description:
This contract supports the advanced development of promising therapeutic candidates with broad spectrum activity. The research and development activities to be supported will allow candidate therapeutic products to progress through the product development pipeline, and includes preclinical and non-clinical activities, as well as IND development activities.
 
Project Terms:
advanced development biodefense development disease ebola virus filovirus medical pre-clinical product development research and development support contracts therapeutic therapeutic development clinical research emerging infectious diseases infectious diseases rare diseases
Project Title: Development of medical countermeasures for biodefense and emerging diseases
Project Number: 272201300017C-18-0-1
Project web address: Follow on NIH
Organization: Biocryst Pharmaceuticals, Inc., United States, Alabama, BIRMINGHAM
Principal Investigators (PI): Taylor Raymond, US
 
Project Categories:
Natural Sciences > Aging Diseases and Pathology
 
Other Information:
Fiscal Year: 2015
Project Start Date: 13 February 2015
Project End Date: 15 September 2017
 
Project Funding Information:
Funding Mechanism: Non SBIR/STTR Contracts
Year Funding Organization Total Funding, $
2016 NIH - National Institute Of Allergy And Infectious Diseases $9,601,843
Project Title: Development of medical countermeasures for biodefense and emerging diseases
Project Number: 272201300017C-18-0-1
Project web address: Follow on NIH
Organization: Biocryst Pharmaceuticals, Inc., United States, Alabama, BIRMINGHAM
Principal Investigators (PI): Taylor Raymond, US
 
Title FY Funding
There are no results for this project in database.
Project Title: Development of medical countermeasures for biodefense and emerging diseases
Project Number: 272201300017C-18-0-1
Project web address: Follow on NIH
Organization: Biocryst Pharmaceuticals, Inc., United States, Alabama, BIRMINGHAM
Principal Investigators (PI): Taylor Raymond, US
 
Project number Project title Principal investigator
There are no any related projects.
Project Title: Development of medical countermeasures for biodefense and emerging diseases
Project Number: 272201300017C-18-0-1
Project web address: Follow on NIH
Organization: Biocryst Pharmaceuticals, Inc., United States, Alabama, BIRMINGHAM
Principal Investigators (PI): Taylor Raymond, US
 
Title Journal Year Country Rel